Bruceoside B

Overview

Bruceoside B is a PI3K/Akt/NF-κB inhibitor . Bruceoside B reduces LPS ( HY-D1056 )-induced nitric oxide release and the secretion of TNF-α, IL-6 and IL-1β, and decreases the activation level of apoptosis . Bruceoside B inhibits the replication, coat protein accumulation and local lesion formation of tobacco mosaic virus ( TMV ), and enhances the anti-infection ability of plants . Bruceoside B can be used in studies related to acute lung injury and tobacco mosaic virus infection .

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Viral Infection | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Respiratory Inflammation | Products > Disease Areas > Plant Infection | Products > Disease Areas > Tobacco Mosaic Virus Infection | Products > Disease Areas > Acute Lung Injury | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > TMV | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Akt | Products > Signaling Pathways > PI3K

Product Information

• Catalog No.: HY-N20733
• CAS No.: 69687-69-0
• Molecular Formula: C32H42O16
• Molecular Weight: 682.67
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source